Search clinical trials for: Velcade
Total 633 results
-
St. Jude Children's Research HospitalAbbVieNot yet recruitingT-cell Lymphoma | T-cell Acute Lymphoblastic Leukemia | Mixed Phenotype Acute LeukemiaUnited States
-
Jin Lu, MDRecruiting
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaKorea, Republic of, Italy, Germany, France, Japan, Israel, Belgium, Denmark, Sweden, Canada, Spain, Czechia, Poland, Australia, Netherlands, United Kingdom, India, China
-
Stichting European Myeloma NetworkJanssen PharmaceuticaRecruitingMultiple MyelomaAustria, Greece, Italy, Netherlands, Germany
-
National Cancer Institute (NCI)Recruiting
-
Wuhan Union Hospital, ChinaRecruitingMultiple Myeloma | Extramedullary Multiple Myeloma | Primary Plasma Cell LeukemiaChina
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Not yet recruiting
-
University of Heidelberg Medical CenterSanofi; KKS Netzwerk; Deutsche Studiengruppe Multiples Myelom (DSMM)Recruiting
-
University Hopsital Schleswig Holstein Campus LübeckRecruitingNewly Diagnosed Multiple MyelomaGermany
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Recruiting
-
CelgeneRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Australia, Italy, China, Spain, Germany, Romania, Korea, Republic of, Japan, United Kingdom, Czechia, Finland, France, Greece, Argentina, Belgium, Austria, Portugal, Israel, Poland, Brazil, Turkey, Canada, Ireland, New Zealand and more
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
First Affiliated Hospital of Zhejiang UniversityNot yet recruitingAdvanced Biliary Tract CarcinomaChina
-
Xia ZhongjunAntengene CorporationRecruiting
-
Mayo ClinicRecruitingPlasma Cell MyelomaUnited States
-
NYU Langone HealthRecruiting
-
Canadian Myeloma Research GroupNot yet recruiting
-
University of Alabama at BirminghamJanssen Scientific Affairs, LLCRecruitingMultiple MyelomaUnited States
-
Jiuda ZhaoSecond Hospital of Lanzhou UniversityRecruiting
-
Regeneron PharmaceuticalsRecruitingMultiple MyelomaUnited States, Spain, France, Greece
-
Shengjing HospitalRecruitingHER2-positive Gastric CancerChina
-
CelgeneRecruitingMultiple MyelomaAustria, Italy, China, Australia, Spain, United States, Korea, Republic of, Taiwan, Germany, Ireland, Argentina, Brazil, Mexico, Netherlands, Belgium, Czechia, France, Greece, Japan, Poland, Israel, United Kingdom, Norway, Denmark, Finland and more
-
Omar Nadeem, MDJanssen, LPRecruitingMultiple Myeloma | High-risk Smoldering Multiple MyelomaUnited States
-
Emory UniversityNational Cancer Institute (NCI); SanofiRecruitingAL AmyloidosisUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingMantle Cell LymphomaUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingPlasma Cell Myeloma | RISS Stage I Plasma Cell Myeloma | RISS Stage II Plasma Cell MyelomaUnited States
-
Karyopharm Therapeutics IncRecruiting
-
Emory UniversityNational Cancer Institute (NCI); Janssen Scientific Affairs, LLCRecruitingRenal Failure | Plasma Cell MyelomaUnited States
-
Peking Union Medical College HospitalNot yet recruitingCervical Cancer | Chemotherapy
-
AHS Cancer Control AlbertaTom Baker Cancer CentreRecruitingMyeloma | Myeloma MultipleCanada
-
Baylor Research InstituteRecruiting
-
Medical College of WisconsinRecruitingMultiple MyelomaUnited States
-
RenJi HospitalNot yet recruiting
-
University of Turin, ItalyRecruiting
-
National University Hospital, SingaporeNational University of SingaporeRecruiting
-
Shahid Beheshti University of Medical SciencesRecruitingAntibody-mediated RejectionIran, Islamic Republic of
-
University of ChicagoRecruiting
-
Sun Yat-sen UniversityRecruitingMyeloma | Newly Diagnosed | High RiskChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Adult Lymphoblastic Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | Recurrent... and other conditionsUnited States
-
University of LeedsCelgene; Janssen, LP; Myeloma UKActive, not recruiting
-
Christian BuskeHoffmann-La Roche; Johnson & Johnson; ClinAssess GmbH; University of Ulm; Zentrum...Active, not recruitingWaldenstrom MacroglobulinemiaGermany, Greece
-
Karyopharm Therapeutics IncBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States, Canada
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States
-
TakedaActive, not recruiting
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaAustralia, Poland, United Kingdom, United States, Belgium, Germany, Spain, Argentina, Portugal, Bulgaria, Romania, Serbia, Turkey, Ukraine, Japan, Greece, Korea, Republic of, Brazil, Russian Federation, Hungary, Czechia, Croatia, Ge... and more
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaCanada, United States, Israel, Czechia, Turkey, Germany, United Kingdom, Japan, Netherlands, France, Brazil, Poland, Spain
-
Janssen Research & Development, LLCCompletedMultiple MyelomaKorea, Republic of, Malaysia, China, Taiwan, Hong Kong
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedMultiple MyelomaUnited States, Philippines, United Kingdom
-
Giselle ShollerBeat NB Cancer Foundation; Because of Ezra; K C Pharmaceuticals Inc.CompletedNeuroblastoma RecurrentUnited States
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Myeloid Neoplasm | Myeloid Sarcoma | Leukemia CutisUnited States, Canada, Australia, New Zealand, Puerto Rico